ConductScience.org, home

Paper356975

Cell kinetics and chemotherapy: a critical review.

Tannock I. Cancer Treat Rep, 1978. Cited by 231 papers, by iCite.

Cite this record

ConductScience Library. Cell kinetics and chemotherapy: a critical review. Papers, record 356975. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/356975

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell kinetics and chemotherapy: a critical review.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
231
iCite
Relative citation ratio, by iCite
6.79
iCite
Revised in PubMed
2015-11-19
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tannock II

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell DivisionMajor topic
NeoplasmsMajor topic
Animals
Autoradiography
Bone Marrow Cells
Cell Cycle
Clone Cells
Drug Administration Schedule
Humans
Kinetics
Leukemia
Thymidine

Source PubMed

Download CSV of topics

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.

PMIDTitleJournalYearIn PapersSource
37790761Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment.Front Oncol2023https://conductscience.org/library/papers/37790761PubMed
36646904Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors.Oncogene2023https://conductscience.org/library/papers/36646904PubMed
36405317Synthesis, biological evaluation, and molecular docking of novel hydroxyzine derivatives as potential AR antagonists.Front Chem2022https://conductscience.org/library/papers/36405317PubMed
34716976How translational modeling in oncology needs to get the mechanism just right.Clin Transl Sci2022https://conductscience.org/library/papers/34716976PubMed
33228140A Short Review on Biomedical Applications of Nanostructured Bismuth Oxide and Related Nanomaterials.Materials (Basel)2020https://conductscience.org/library/papers/33228140PubMed
32799866CircRNAs in anticancer drug resistance: recent advances and future potential.Mol Cancer2020https://conductscience.org/library/papers/32799866PubMed
32049575The effects of proliferation status and cell cycle phase on the responses of single cells to chemotherapy.Mol Biol Cell2020https://conductscience.org/library/papers/32049575PubMed
31131698Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000.Cancer Biol Ther2019https://conductscience.org/library/papers/31131698PubMed
31011405Spontaneous Tumor Lysis Syndrome in Childhood T cell Acute Lymphoblastic Leukemia.Oman Med J2013https://conductscience.org/library/papers/31011405PubMed
29799080The challenge of drug resistance in cancer treatment: a current overview.Clin Exp Metastasis2018https://conductscience.org/library/papers/29799080PubMed
29109383Synthesis and Antitumor Activity of Novel Arylpiperazine Derivatives Containing the Saccharin Moiety.Molecules2017https://conductscience.org/library/papers/29109383PubMed
28504252Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.Acta Pharmacol Sin2017https://conductscience.org/library/papers/28504252PubMed
26904687Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions.Biomed Res Int2016https://conductscience.org/library/papers/26904687PubMed
23805101Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy.Front Pharmacol2013https://conductscience.org/library/papers/23805101PubMed
22160948Anticancer effects of 5-fluorouracil combined with warming and relieving cold phlegm formula on human breast cancer.Chin J Integr Med2012https://conductscience.org/library/papers/22160948PubMed
19500391Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy.BMC Cancer2009https://conductscience.org/library/papers/19500391PubMed
19002794New insights into the kinetic resistance to anticancer agents.Cytotechnology1998https://conductscience.org/library/papers/19002794PubMed
18854836Cell cycle times of short-term cultures of brain cancers as predictors of survival.Br J Cancer2008https://conductscience.org/library/papers/18854836PubMed
12915875DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer.Br J Cancer2003https://conductscience.org/library/papers/12915875PubMed
10455409Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule.Gene Ther1999https://conductscience.org/library/papers/10455409PubMed

See all 39 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/356975

GET https://conductscience.org/api/papers/v1/356975/cited_by?page=2